AstraZeneca
AZN | NYSE
$186.65
+$12.25 (+7.02%)
At close: Oct 30, 2026, 4:00 PM ET
$184.90
-$1.75 (-0.94%)
Pre-market:
Nov 2, 2026, 8:04 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 11.28B | 11.93B | 10.93B | 10.24B | 9.54B | 8.81B | 8.69B | 7.92B | 7.75B | 7.44B | 6.9B | 6.78B | 6.05B | 4.21B | 2.5B | 1.09B | -1.84B | -1.53B | -479M | 1.17B | 4.02B | 4.43B |
Depreciation & Amortization | 6.35B | 5.83B | 5.75B | 4.94B | 5.2B | 5.09B | 5.07B | 5.23B | 4.69B | 4.69B | 4.93B | 5.54B | 5.59B | 5.67B | 5.48B | 6.19B | 7.65B | 7.04B | 6.53B | 4.88B | 2.9B | 2.85B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 579M | 579M | 579M | 579M | 619M | 619M | 619M | 619M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -1.83B | -1.74B | -1.16B | -286M | -1.08B | -864M | -893M | -693M | 163M | -697M | n/a | -2.14B | -1.97B | -397M | 1.17B | 1.4B | 1.53B | 594M | n/a | 2.32B | 1.64B | 1.66B |
Other Non-Cash Items | -1.99B | -1.72B | -857.99M | 248M | -272M | 51M | -1B | -1.42B | -1.83B | -2.03B | -1.79B | -2.41B | -2.08B | -2.37B | -1.93B | -462M | -342M | 543M | -704M | -666M | -749M | -987M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -579M | -579M | -579M | -579M | -619M | -619M | -619M | -619M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.83B | -1.74B | -1.16B | -286M | -1.08B | -864M | -893M | -393M | 463M | -397M | 300M | 449M | 619M | 2.2B | 3.76B | 2.01B | 2.15B | 1.21B | 616M | 958M | 277M | 295M |
Operating Cash Flow | 13.81B | 14.31B | 14.66B | 15.14B | 13.39B | 13.09B | 11.86B | 11.33B | 11.07B | 9.7B | 10.35B | 10.36B | 10.18B | 9.71B | 9.81B | 8.83B | 7.62B | 7.26B | 5.96B | 6.34B | 6.45B | 6.59B |
Capital Expenditures | -5.07B | -6.24B | -5.67B | -5.57B | -5.21B | -3.95B | -4.59B | -4.58B | -4.1B | -3.91B | -3.78B | -3.39B | -3.62B | -3.68B | -2.57B | -2.74B | -2.28B | -2.03B | -2.14B | -1.97B | -2.01B | -2.7B |
Cash Acquisitions | -906.69M | -1.14B | -1.23B | -1.24B | -1.18B | -3.21B | -3.79B | -3.81B | -3.81B | -1.69B | -1.18B | -1.07B | -1.14B | -1.25B | -1.06B | -1.09B | -10.38B | -10.23B | -9.43B | -9.37B | -57M | -105M |
Purchase of Investments | -94.31M | -321.54M | -228.54M | -218M | -217M | 2M | -96M | -111M | -177M | -234M | -136M | 69M | -157M | -155M | -159M | -343M | -202M | -178M | 75M | 254M | 911M | 907M |
Sales Maturities Of Investments | 18.78M | 129.82M | 130.82M | 90M | 130M | 100M | 108M | 237M | 122M | 119M | 129M | 32M | 98M | 8M | 42M | 27M | 14M | 23M | -2M | 488M | 742M | 1.87B |
Other Investing Acitivies | -1.67B | -2.89B | -2.48B | -2.69B | -2.57B | -1.77B | -2.28B | -2.03B | -1.1B | -698M | 900M | 1.12B | 1.06B | 1.03B | 789M | 517M | 502M | 628M | 437M | 590M | 291M | 286M |
Investing Cash Flow | -8.25B | -7.42B | -6.88B | -6.54B | -6.06B | -6.82B | -7.98B | -7.88B | -7.58B | -5.23B | -4.06B | -3.24B | -3.76B | -4.04B | -2.96B | -3.62B | -12.35B | -11.78B | -11.06B | -10.01B | -123M | 261M |
Debt Repayment | -1.67B | 1.38B | -1.75B | 731.35M | -1.3B | -3.07B | 1.81B | 2.18B | 3.39B | 3.09B | -965M | -801M | 466M | 667M | -955M | -1.74B | -198M | 372M | -119M | -925M | -48M | 1.8B |
Common Stock Repurchased | -257.91M | -211.58M | -211.58M | -12.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -4.88B | -4.89B | -4.95B | -4.96B | -4.94B | -4.94B | -4.63B | -4.63B | -4.46B | -4.47B | -4.48B | -4.58B | -4.56B | -4.63B | -4.56B | -4.47B | -4.46B | -4.36B | -3.85B | -3.81B | -3.6B | -3.62B |
Other Financial Acitivies | -340.46M | -358.46M | -263.46M | -245.76M | -224M | -195M | -1.13B | -1.12B | -1.18B | -1.16B | -1.15B | -1.28B | -1.27B | -1.18B | -1.34B | -1.34B | -1.31B | 6.62B | 7.61B | 7.22B | 7.23B | -782.83M |
Financial Cash Flow | -7.72B | -4.65B | -7.62B | -4.94B | -6.99B | -8.73B | -4B | -3.62B | -2.21B | -2.51B | -6.57B | -6.63B | -5.34B | -5.11B | -6.82B | -7.52B | -5.94B | 2.64B | 3.65B | 2.49B | 3.59B | -2.57B |
Net Cash Flow | -2.24B | 2.28B | 240.53M | 3.65B | 355M | -2.49B | -208M | -184M | 1.21B | 1.86B | -346M | 433M | 991M | 475M | -55M | -2.39B | -10.72B | -1.88B | -1.51B | -1.22B | 9.89B | 4.26B |
Free Cash Flow | 8.74B | 8.07B | 8.99B | 9.57B | 8.18B | 9.14B | 7.28B | 6.76B | 6.97B | 5.79B | 6.57B | 6.98B | 6.56B | 6.03B | 7.24B | 6.09B | 5.33B | 5.23B | 3.83B | 4.38B | 4.44B | 3.9B |
Adj. Free Cash Flow | 8.74B | 8.07B | 8.99B | 9.57B | 8.18B | 9.14B | 7.28B | 6.18B | 6.39B | 5.21B | 5.99B | 6.36B | 5.94B | 5.41B | 6.62B | 6.09B | 5.33B | 5.23B | 3.83B | 4.38B | 4.44B | 3.9B |
Maintenance CapEx | -4.33B | -5.12B | -4.49B | -3.8B | -3.3B | -2.03B | -2.43B | -2.94B | -2.86B | -2.89B | -3.23B | -3.06B | -3.11B | -2.81B | -1.34B | -783.68M | n/a | n/a | -171.1M | -492.59M | -1.15B | -1.99B |
Growth CapEx | -738.24M | -1.12B | -1.18B | -1.77B | -1.9B | -1.92B | -2.15B | -1.64B | -1.24B | -1.02B | -551.57M | -323.05M | -507.73M | -870.32M | -1.23B | -1.95B | -2.28B | -2.03B | -1.96B | -1.47B | -864.63M | -713.86M |
Owner Earnings | 9.48B | 9.19B | 10.17B | 11.34B | 10.09B | 11.05B | 9.43B | 8.39B | 8.2B | 6.81B | 7.12B | 7.3B | 7.07B | 6.9B | 8.47B | 8.04B | 7.62B | 7.26B | 5.79B | 5.85B | 5.3B | 4.61B |
Add to Watchlist
Select watchlists to add or remove AZN